AngioDynamics, Inc. (ANGO)
USD 8.93
(-3.56%)
USD 8.93
(-3.56%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -14.29 Million USD | -217.21% |
| 2023 | 12.19 Million USD | 12.55% |
| 2022 | 11.13 Million USD | -6.37% |
| 2021 | -8.89 Million USD | 14.61% |
| 2020 | -143.73 Million USD | -90.24% |
| 2019 | 10.55 Million USD | 100.11% |
| 2018 | 3.1 Million USD | -18.09% |
| 2017 | 12.96 Million USD | 7.42% |
| 2016 | 26.29 Million USD | -15.38% |
| 2015 | 22.91 Million USD | 17.19% |
| 2014 | 37.32 Million USD | -14.99% |
| 2013 | 34.75 Million USD | 48.8% |
| 2012 | 8.26 Million USD | 10.95% |
| 2011 | 23.77 Million USD | 16.58% |
| 2010 | 32.75 Million USD | 16.37% |
| 2009 | 27.69 Million USD | 0.92% |
| 2008 | 16.23 Million USD | 462.21% |
| 2007 | -7.81 Million USD | -172.42% |
| 2006 | 11.38 Million USD | 28.12% |
| 2005 | 8.49 Million USD | 50.96% |
| 2004 | 5.8 Million USD | 49.01% |
| 2003 | 3.89 Million USD | 31.72% |
| 2002 | 2.95 Million USD | -69.02% |
| 2001 | 9.54 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -47.8 Million USD | 76.25% |
| 2024 Q3 | -4.07 Million USD | -26730.77% |
| 2024 FY | - USD | -152.37% |
| 2024 Q4 | 1.01 Million USD | -4.99% |
| 2024 Q2 | 6.38 Million USD | 99.15% |
| 2023 Q1 | -24 Thousand USD | -100.72% |
| 2023 Q2 | 4.15 Million USD | 17416.67% |
| 2023 Q3 | 2.5 Million USD | -39.7% |
| 2023 Q4 | 5 Million USD | 99.6% |
| 2023 FY | - USD | 12.55% |
| 2022 FY | - USD | -6.37% |
| 2022 Q4 | 3.32 Million USD | -24.05% |
| 2022 Q3 | 4.38 Million USD | 201.79% |
| 2022 Q2 | 1.45 Million USD | 23.05% |
| 2022 Q1 | 1.18 Million USD | -49.23% |
| 2021 Q4 | 2.32 Million USD | -28.95% |
| 2021 Q3 | 3.27 Million USD | 16.41% |
| 2021 FY | - USD | 14.61% |
| 2021 Q2 | 2.81 Million USD | 6.4% |
| 2021 Q1 | 2.64 Million USD | 234.74% |
| 2020 FY | - USD | -90.24% |
| 2020 Q4 | -1.96 Million USD | -195.28% |
| 2020 Q3 | 2.05 Million USD | -51.12% |
| 2020 Q2 | 4.2 Million USD | -21.1% |
| 2020 Q1 | 5.33 Million USD | -91.41% |
| 2019 Q2 | 13.72 Million USD | 31.05% |
| 2019 FY | - USD | 100.11% |
| 2019 Q1 | 10.47 Million USD | -22.23% |
| 2019 Q4 | 62.05 Million USD | 394.57% |
| 2019 Q3 | 12.54 Million USD | -8.58% |
| 2018 Q2 | 11.57 Million USD | -4.5% |
| 2018 Q1 | 12.12 Million USD | -49.99% |
| 2018 FY | - USD | -18.09% |
| 2018 Q4 | 13.46 Million USD | -8.62% |
| 2018 Q3 | 14.73 Million USD | 27.32% |
| 2017 FY | - USD | 7.42% |
| 2017 Q2 | 5.54 Million USD | -56.16% |
| 2017 Q3 | 15.05 Million USD | 171.67% |
| 2017 Q4 | 24.23 Million USD | 61.01% |
| 2017 Q1 | 12.63 Million USD | 1.34% |
| 2016 Q3 | 15.68 Million USD | -7.46% |
| 2016 Q1 | 9.84 Million USD | -36.98% |
| 2016 FY | - USD | -15.38% |
| 2016 Q2 | 16.95 Million USD | 72.15% |
| 2016 Q4 | 12.47 Million USD | -20.5% |
| 2015 FY | - USD | 17.19% |
| 2015 Q1 | 17.72 Million USD | 1.06% |
| 2015 Q4 | 15.62 Million USD | -2.92% |
| 2015 Q3 | 16.09 Million USD | -9.2% |
| 2015 Q2 | 17.72 Million USD | 0.0% |
| 2014 Q3 | 11.91 Million USD | 10.76% |
| 2014 Q1 | 9.43 Million USD | -43.65% |
| 2014 Q4 | 17.54 Million USD | 47.25% |
| 2014 Q2 | 10.75 Million USD | 14.04% |
| 2014 FY | - USD | -14.99% |
| 2013 Q1 | 16.88 Million USD | 8.57% |
| 2013 FY | - USD | 48.8% |
| 2013 Q4 | 16.73 Million USD | -9.25% |
| 2013 Q3 | 18.44 Million USD | 15.68% |
| 2013 Q2 | 15.94 Million USD | -5.56% |
| 2012 Q1 | 8.3 Million USD | -42.95% |
| 2012 FY | - USD | 10.95% |
| 2012 Q4 | 15.54 Million USD | 46.18% |
| 2012 Q3 | 10.63 Million USD | 3.87% |
| 2012 Q2 | 10.24 Million USD | 23.24% |
| 2011 Q2 | 9.34 Million USD | 39.96% |
| 2011 FY | - USD | 16.58% |
| 2011 Q4 | 14.56 Million USD | 70.27% |
| 2011 Q1 | 6.67 Million USD | -32.12% |
| 2011 Q3 | 8.55 Million USD | -8.46% |
| 2010 Q4 | 9.83 Million USD | 10.98% |
| 2010 FY | - USD | 16.37% |
| 2010 Q3 | 8.86 Million USD | 9.95% |
| 2010 Q1 | 6.84 Million USD | -16.68% |
| 2010 Q2 | 8.06 Million USD | 17.82% |
| 2009 FY | - USD | 0.92% |
| 2009 Q1 | 7.15 Million USD | -24.79% |
| 2009 Q4 | 8.21 Million USD | 33.83% |
| 2009 Q3 | 6.13 Million USD | -28.71% |
| 2009 Q2 | 8.6 Million USD | 20.29% |
| 2008 Q2 | 7.28 Million USD | 29.75% |
| 2008 FY | - USD | 462.21% |
| 2008 Q3 | 7.03 Million USD | -3.51% |
| 2008 Q1 | 5.61 Million USD | -3.42% |
| 2008 Q4 | 9.51 Million USD | 35.3% |
| 2007 Q3 | -19.07 Million USD | -670.31% |
| 2007 FY | - USD | -172.42% |
| 2007 Q2 | 3.34 Million USD | 86.98% |
| 2007 Q4 | 5.81 Million USD | 130.48% |
| 2007 Q1 | 1.78 Million USD | -47.64% |
| 2006 Q2 | 2.59 Million USD | 23.52% |
| 2006 Q4 | 3.41 Million USD | 9.73% |
| 2006 Q3 | 3.11 Million USD | 20.05% |
| 2006 Q1 | 2.1 Million USD | -22.37% |
| 2006 FY | - USD | 28.12% |
| 2005 Q4 | 2.7 Million USD | 3.2% |
| 2005 FY | - USD | 50.96% |
| 2005 Q3 | 2.62 Million USD | 32.11% |
| 2005 Q1 | 1.45 Million USD | -29.74% |
| 2005 Q2 | 1.98 Million USD | 36.55% |
| 2004 Q3 | 1.06 Million USD | 0.0% |
| 2004 Q4 | 2.06 Million USD | 93.63% |
| 2004 FY | - USD | 49.01% |
| 2003 FY | - USD | 31.72% |
| 2003 Q4 | -9.02 Million USD | -232.68% |
| 2003 Q3 | 6.8 Million USD | 0.0% |
| 2002 FY | - USD | -69.02% |
| 2001 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -45.63 Million USD | 68.68% |
| AtriCure, Inc. | -8.1 Million USD | -76.249% |
| Avinger, Inc. | -16.34 Million USD | 12.566% |
| Azenta, Inc. | 55.15 Million USD | 125.914% |
| BioLife Solutions, Inc. | -45.23 Million USD | 68.407% |
| The Cooper Companies, Inc. | 882.8 Million USD | 101.619% |
| Daxor Corporation | 329.74 Thousand USD | 4434.324% |
| Ekso Bionics Holdings, Inc. | -13.19 Million USD | -8.289% |
| Femasys Inc. | -13.16 Million USD | -8.524% |
| GlucoTrack, Inc. | -7.09 Million USD | -101.551% |
| Harvard Bioscience, Inc. | 9.49 Million USD | 250.553% |
| Hologic, Inc. | 1.29 Billion USD | 101.103% |
| ICU Medical, Inc. | 307.69 Million USD | 104.645% |
| Intuitive Surgical, Inc. | 2.39 Billion USD | 100.597% |
| KORU Medical Systems, Inc. | -9.39 Million USD | -52.049% |
| LeMaitre Vascular, Inc. | 48.99 Million USD | 129.173% |
| Innovative Eyewear, Inc. | -6.57 Million USD | -117.364% |
| Innovative Eyewear, Inc. | -6.57 Million USD | -117.364% |
| Masimo Corporation | 236.7 Million USD | 106.038% |
| Microbot Medical Inc. | -10.63 Million USD | -34.399% |
| Meihua International Medical Technologies Co., Ltd. | 15.77 Million USD | 190.625% |
| Merit Medical Systems, Inc. | 231.44 Million USD | 106.175% |
| Nephros, Inc. | -1.37 Million USD | -936.403% |
| NovoCure Limited | -175.86 Million USD | 91.873% |
| NEXGEL, Inc. | -2.73 Million USD | -423.516% |
| NEXGEL, Inc. | -2.73 Million USD | -423.516% |
| Singular Genomics Systems, Inc. | -86.49 Million USD | 83.477% |
| OraSure Technologies, Inc. | 76.15 Million USD | 118.766% |
| Pro-Dex, Inc. | 8.33 Million USD | 271.511% |
| Pulse Biosciences, Inc. | -42.36 Million USD | 66.266% |
| Predictive Oncology Inc. | -13.18 Million USD | -8.42% |
| Precision Optics Corporation, Inc. | -2.51 Million USD | -468.96% |
| QuidelOrtho Corporation | 545.6 Million USD | 102.62% |
| Repligen Corporation | 124.29 Million USD | 111.499% |
| Sanara MedTech Inc. | -289.09 Thousand USD | -4843.669% |
| STAAR Surgical Company | 33.22 Million USD | 143.021% |
| Sharps Technology, Inc. | -8.98 Million USD | -59.147% |
| Utah Medical Products, Inc. | 24.8 Million USD | 157.617% |
| DENTSPLY SIRONA Inc. | 232 Million USD | 106.16% |
| Jin Medical International Ltd. | 3.44 Million USD | 515.117% |